Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQITM ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients

Nephrology Dialysis Transplantation

Volumn 23, Issue 7, 2008, Pages 2319-2323

  Mazzaferro, Sandro ^a   Pasquali, Marzia ^a   Farcomeni, Alessio ^b   Vestri, Anna Rita ^b   Filippini, Angelo ^a   Romani, Anna Maria ^a   Barresi, Giusi ^a   Pugliese, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

NKF K DOQI guidelines; Parathyroid hormone; Parathytroidectomy; Secondary hyperparathyroidism

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

ADULT; AGED; CALCIUM; FEMALE; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, SECONDARY; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; PHOSPHATES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 46849120779     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm931     Document Type: Article

References (22)

1. National Kidney Foundation. K/DOQI clinical practice guidelines: bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(Suppl 4): S1-S201
2. Young EW, Albert JM, Satayathum S et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-1187
3. Young EW, Akiba T, Albert JM et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44(Suppl 2): 34-38
4. Moe SM, Chertow GM, Coburn JW et al. Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 2005; 67: 760-771
5. Lazar E, Hebert K, Poma T et al. Long-term outcomes of cinacalcet and paricalcitol titration protocol for treatment of secondary hyperparathyroidism. Am J Nephrol 2007; 27: 274-278
6. Hutchison AJ, Maes B, Vanwalleghem J et al. Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study. Nephron Clin Pract 2006; 102: c61-c71
7. Tominaga Y, Uchida K, Haba T et al. More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 2001; 38(Suppl 1): S168-S171
8. Stracke S, Jehle PM, Sturm D et al. Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure. Am J Kidney Dis 1999; 33: 304-311
9. Gagne ER, Urena P, Leite-Silva S et al. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol 1992; 3: 1008-1017
10. Neonakis E, Wheeler MH, Krishnan H et al. Results of surgical treatment of renal hyperparathyroidism. Arch Surg 1995; 130: 643-648
11. Donckier V, Decoster-Gervy C, Kinnaert P. Long-term results after surgical treatment of renal hyperparathyroidism when fewer than four glands are identified at operation. J Am Coll Surg 1997; 184: 70-74
12. Zaraca F, Mazzaferro S, Catarci M et al. Prospective evaluation of total parathyroidectomy and autotransplantation for the treatment of secondary hyperparathyroidism. Arch Surg 1999; 134: 68-72
13. Coen G, Calabria S, Bellinghieri G et al. Parathyroidectomy in chronic renal failure: short- and long-term results on parathyroid function, blood pressure and anemia. Nephron 2001; 88: 149-155
14. Yu I, DeVita MV, Komisar A. Long-term follow-up after subtotal parathyroidectomy in patients with renal failure. Laryngoscope 1998; 108: 1824-1828
15. Gasparri G, Camandona M, Abbona GC et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 2001; 233: 65-69
16. Tominaga Y, Katayama A, Sato T et al. Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant 2003; 18(Suppl 3): iii65-iii70.
17. Giessauf H, Braun E, Horn S et al. Achievement of K/DOQI guideline targets after parathyroidectomy in patients with end stage renal disease (ESRD). J Am Soc Nephrol 2006; 17: 260A (TH-PO723)
18. Foley RN, Li S, Liu J et al. The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 2005; 16: 210-218
19. Kestenbaum B, Andress DL, Schwartz SM et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int 2004; 66: 2010-2016
20. Urena P, Eckardt KU, Sarfati E et al. Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: effect of parathyroidectomy. Nephron 1991; 59: 384-393
21. Goldsmith DJ, Covic AC, Venning MC et al. Ambulatory blood pressure monitoring in renal dialysis and transplant patients. Am J Kidney Dis 1997; 29: 593-600
22. Sato S, Ohta M, Kawaguchi Y et al. Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism. Miner Electrolyte Metab 1995; 21: 67-71